Crossmark

Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer

Crossref DOI link: https://doi.org/10.1007/s11605-020-04757-6

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nelson, Daniel W. https://orcid.org/0000-0003-1555-819X
Merritt, Clay

Chang, Shu-Ching

Grunkemeier, Gary

Steele, Scott R.

Goldfarb, Melanie
License Information

Text and Data Mining valid from 2021-01-01

Text and Data Mining valid from 2021-01-01
More Information

This article is maintained by: Elsevier

Article Title: Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer

Journal Title: Journal of Gastrointestinal Surgery

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s11605-020-04757-6

Content Type: article

Copyright: Copyright © 2020 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.

Document is current

Any future updates will be listed below